by Mark Davis | Jul 25, 2025 | Blog
When I started in healthcare mergers and acquisitions, one comprehensive and cohesive acquisition agreement was used to memorialize the transaction. However, over time, when buying healthcare services businesses, lawyers have adopted the practice of two acquisition...
by Mark Davis | Jul 24, 2025 | Blog
Current Market Range (2024-2025): The median EBITDA multiple is 13.0x from the 33 transactions over the 2-year period for physician practices generally, though Emergency Medicine companies typically trade at different ranges based on size and performance. Size-Based...
by Mark Davis | Jul 16, 2025 | Blog
Multiple Compression and Market Corrections The post-acute care sector has experienced valuation adjustments reflecting broader market conditions. More stable subsectors like hospitals weathered the storm remarkably well, experiencing an ~7% reduction in EBITDA...
by Mark Davis | Jul 15, 2025 | Blog
The fundamental demographic drivers supporting post-acute care M&A remain compelling. The home care sector, which includes Medicare-certified home health, hospice, personal care, and other specialty providers, represents an attractive investment opportunity for...
by Mark Davis | Jul 14, 2025 | Blog
The post-acute healthcare sector stands at a critical juncture as we progress through 2025, with mergers and acquisitions activity reflecting both the enduring fundamentals driving consolidation and the mounting challenges reshaping deal dynamics. From home health and...
by Mark Davis | Jan 7, 2025 | Blog
As a Mergers and Acquisitions Advisor, if you call Healthcare Transactions Group (HTG) to discuss the possibility of engaging us to sell your business, and HTG does not sign a Confidentiality Agreement, does HTG nonetheless have an implied obligation to maintain this...